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a stable phase of the disease). Clinical follow-up of all pts was performed for
12 months.
Results: CRP values (normal <3 mg/l) are expressed as median and range.
At discharge, 13/34 pts (38%) had a CRP value >3 mgll (9 mgll, range 3.6-
29.2). and 21/34 pts (62%) had a CRP value <3 mgll (2.4 mgll, range 0.6-2.8).
All 13 pts with elevated CRP at discharge, but one, had elevated levels of
CRP also at 3 months, and 9 of them had a coronary event (2 pts myocardial
infarction, 7 pts recurrence of instability) within one year of follow-up (mean
159 ± 91 days). Conversely, only 1/21 pts with low CRP at discharge had a
myocardial infarction at 10 months (p < 0.001 vs pts with elevated levels at
dischargel; of note, at 3 months also this pt had increased levels of CRP
Conclusions: Our data suggest that in pts with UA, elevated CRP levels
at discharge and at 3 months (during a quiescent phase of the disease) are
associated with new coronary events (recurrence of instability and acute my-
ocardial infarction).
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Differential Response of Left Ventricular Work
Efficiency and Inotropy to Dobutamine in the
Failing Canine Heart
Peter S. Rahko, Catherine R. Kidd, Alice M. Eggleston, Larry F Whitesell.
Cardiology Section, University of Wisconsin, Madison, WI
Left ventricular work efficiency (LVWE). a measure of the efficiency of energy
transfer from LV to systemic circulation, declines as heart failure ICHF) be-
comes more severe. We compared changes in the response of LVWE and
inotropy to dobutamine as progressively more severe CHF was induced by
tachypacing. Seventeen dogs (weights 19-24 kg) were instrumented with
micromanometer catheters, Ultrasonic crystals and a pacemaker and paced
at 215-240 bpm over 3 weeks. Ventricular volumes and pressures were dig-
itally acquired at baseline and weekly over 3 weeks. Pressure-volume area
(PVA), external work (EWI, end-systolic pressure-volume relation slope (E es )
and arterial elastance (Eal were derived from variably loaded beats after IVC
occlusion. The LVWE was calculated as EW/PVA. Measurements were made
with and without dobutamine (DOB) at 10 /Lg/kg/min.
Results:
Baseline CHF 1 CHF 2 CHF 3
EW{mmHg-ml) 1308 ± 663 1050 ± 542 861 ± 633- 738 ± 506-
% t on DOB +80 ± 34 +133 ± 71 +145± 89 +222 ± 188-
LVWE(%) 52 ± 8 42 ± 10- 36 ± 10- 33 ± ,,-
% t on DOB +65 ± 27 +77 ± 26 +108 ± 77- +115 ± 12-
Ees (mmHg/ml) 5.1 ± 2.9 3.8 ± 1.6 2.9 ± 1.6- 2.5 ± 10-
% t on DOB +269± 159 +135 ± 118- +125±31- +131 ± 58-
peak + dP/dt (mmHg/sl 1680 ± 482 1312 ± 354- 1008 ± 178- 1080 ± 325-
% ton DOB +162 ± 63 105 ± 49- lOB ± 52- +81 ± 42-
Ea/Ees ratio 20±08 3.7 ± 2.4- 4.1 ± 22- 4.1 ± 1.6-
%. on DOB -78± 11 -72 ± 9 -73 ± 9 -65 ± 4-
-p < 0.05 vs baseline
LV mass regression, since it exceedS 2 standard deviations of test-retest
reliability of M-mode echocardiography; such a large reduction in LV mass
should allow the detection of functional changes that accompany hypertro-
phy regression. Circumferential stress (ac, g/cm2) vs endocardial fractional
shortening (FSendo, %) relations were used to characterize LV function; ac
vs midwall fractional shortening (FSmw, %) was used to define myocardial
function. FSmw was derived from a two-shell model that accounts for non-
uniform wall thickening, is independent of relative wall thickness (RWT) and
is anatomically appropriate, since midwall fibers are oriented circumferen-
tially. Thd and Dd are LV diastolic wall thickness and diastolic dimension
(mm); SBP ~ systolic pressure;
Data are mean ± SE.
SBP Th d Dd RWT LVMass FSendo FSmw ac
baseline 153 ± 4 14 ± 1 56 ± 1 0.50 ± 0.03 438 ± 26 39 ± 2 20 ± 1 95 ± 10
1year 139 ± 4- 11 ± 1- 52 ± 2- 0.46 ± 0.03326 ± 24- 36 ± 2 20 ± 1 106 ± 12-
-P < 005 vs baseline
A significant decrease in SSP was accompanied by a substantial reduction
in LV mass and a significant, albeit small, increment in aC. The increase in ac
was associated with a small (p = NS) decrease in FSendo and no change in
FSmw. Thus major changes in mass associated with anti-hypertensive ther-
apy are not accompanied by a decrement in LV or myocardial function. In-
deed the unchanged FSmw in the presence of increased ac suggests im-
proved myocardial contractile function.
Combination of Myocardial Contrast
Echocardiography and Dobutamine
Echocardlography In the Assessment of
Myocardial Viability
Mario F. Meza, Marc A. Kates, R. Wayne Barbee, Susan Revall, Sameh Mobarek,
Joseph P. Murgo, Jorge Cheirif. Ochsner Medical Institutions, New Orleans, LA
Independent studies using myocardial contrast echocardiography (MCE)
and dobutamine-echocardiography have suggested that each of these tech-
niques can individually identify viable myocardium. To determine if the com-
bination of these techniques can be used to differentiate viable from non-
viable myocardium, we studied 35 open-chest dogs in which coronary oc-
clusions of various durations were performed (15 minutes to 360 minutes).
Myocardial contrast echocardiography (area under the time-intensity curve)
was performed with injections of sonicated albumin (Albunex®) in the aortic
root at baseline, during occlusion, and following reperfusion with and with-
out dobutamine administration. Regional function [% wall thickening (WT)],
was assessed during all interventions. Criteria for viability were: return of
perfusion (by MCE) and regional function (by WT) to preocclusion levels and
postmortem TIC staining (+ stain = viable myocardium). Results as shown
below (MI = myocardial infarction):
Sensitivity Specificity
Group MCE WT MCE + WT MCE WT MCE +WT
No Dobutamine:
NoMI 4B 36 61 100 100 100
MI 100 100 100 48 52 56
With Dobutamine:
NoMI 60 52 87 43 57 60
MI 100 86 100 60 52 62
Gerard P Aurigemma, John S. Gottdiener, William H. Gaasch. DaVid Williams,
Zahid Jamal, Domenic J. Reda, Barry J. Materson. University of Massachusetts
Medical School, Worcester, MA; Georgetown University Hospital. Washington D. C;
Department of Veterans Affairs
The inotropic responsiveness of the LV is significantly reduced in CHF as
demonstrated by the response of Ees and +dP/dt to DOB. However, EW on
DOB in CHF is not significantly different than at baseline (1924 ± 1205 vs
2269 ± 1051 mmHg-ml). This is caused by a greater increase in LVWE on
DOB in CHF Improved LVWE and Ea/Ees coupling is an important mechanism
for enhanced LV pump performance in CHF and helps counterbalance the
reduction of inotropic responsiveness of the LV as CHF progresses.
It has been hypothesized that left ventricular(LV)function may deteriorate fol-
lOWing reduction in LV mass in treated hypertensives. We therefore assessed
ventricular and myocardial function follOWing a substantial regression of LV
mass (~80 g) after 1 year of antihypertensive treatment in 17 patients. These
pts were part of a cohort of 239 undergoing echocardiography at baseline
and 1 year who took part in a multicenter VA cooperative study of monother-
apy in hypertension. We hypothesized that an 80 g reduction represents true
In conclusion, combination MCE-dobutamine echocardiography improves
the sensitivity and specificity of either technique alone in diagnosing the
presence of viable myocardium. This data could have important clinical im-
plications.
Determinants of Pulmonary Hypertension
Associated with Left Ventricular Dysfunction
MaUrice E. Sarano, James B. Seward, A. Jamil Tajik. Mayo Clinic, Rochester, MN
The elevation of systolic pulmonary artery pressure (S-PAP) is an important
prognostic variable in patients with left ventricular dysfunction (LVD). The
potential determinant of pulmonary hypertension have not been consistently
measured and remain ill defined. In 93 patients (age = 6B ± 13 years) with pri-
mary LVD (Ejection Fraction <50%, mean ± SO = 31 ± 10%), the S-PAP was
prospectively measured using Doppler tricuspid regurgitant velocity. The cor-
relations between S-PAP and LV diastolic volume (R = 0.19, P = NS). LVejec-
tion fraction (R = -0.23, p = 0.024). cardiac index (R = -0.22, P = 0.04). left
atrial volume (R = 0.31, P = 0.002) were weak. Stronger correlations were
observed with mitral regurgitant fraction (R = 0.46, p = 0.0001). effective
regurgitant orifice (ERO, R = 0.48, P = 0.0001), mitral deceleration time (DT)
R = -0.62, P = 0.0001) and E/A ratio (R = 0.43, P = 0.002). With multivariate
analysis, the only independent predictors of S-PAP were mitral deceleration
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